Amdoxovir

DB06619InvestigationalSmall molecule

Investigated for use/treatment in HIV infection and acquired immune deficiency syndrome (AIDS) and aids-related infections.

Chemical structure of Amdoxovir
Mechanism
Curator reviewed
Primary indication
Investigated for use/treatment in HIV infection and acquired immune deficiency syndrome (AIDS) and aids-related infections.Curator reviewed
Formula / weight
C9H12N6O3 · 252.234 g/mol (avg)

Resolves to

Compound
UNII54I81H0M9CCAS145514-04-1ChEMBLCHEMBL458876
Structure
InChIKeyRLAHNGKRJJEIJL-RFZPGFLSSA-NSMILESNC1=NC(N)=C2N=CN([C@H]3CO[C@@H](CO)O3)C2=N1
Targets
Q72547polP03366gag-pol

What you can answer from here — as of June 15, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
5Clinical trialsPhase, status and sponsor resolved per trial
Sign in
6+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Amdoxovir, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In